Provided by Tiger Trade Technology Pte. Ltd.

Whitehawk Therapeutics, Inc.

4.07
-0.1200-2.86%
Post-market: 4.070.00000.00%16:10 EDT
Volume:1.29M
Turnover:5.20M
Market Cap:232.03M
PE:-3.65
High:4.18
Open:4.13
Low:3.99
Close:4.19
52wk High:5.50
52wk Low:1.78
Shares:57.01M
Float Shares:28.74M
Volume Ratio:7.43
T/O Rate:4.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1137
EPS(LYR):-0.3328
ROE:-44.98%
ROA:-28.70%
PB:1.27
PE(LYR):-12.23

Loading ...

WhiteHawk Therapeutics Appoints Vijay Iyengar, Md, to Board of Directors

THOMSON REUTERS
·
9 mins ago

Press Release: Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors

Dow Jones
·
9 mins ago

Whitehawk Therapeutics Joins Morgan Stanley Global Healthcare Conference Fireside Chat

Reuters
·
Sep 02

TD Cowen Remains a Hold on Whitehawk Therapeutics (WHWK)

TIPRANKS
·
Aug 07

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 07

Whitehawk Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Whitehawk Therapeutics Posts Corporate Deck Highlighting ADC Platform and Phase 1 Pipeline Progress

Reuters
·
Aug 06

Whitehawk Q2 FY26 Net Loss Narrows to $16.64 Million

Reuters
·
Aug 06

WhiteHawk Therapeutics Inc Q2 Operating Expenses USD 18.109 Million

THOMSON REUTERS
·
Aug 06

Press Release: Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Dow Jones
·
Aug 06

Whitehawk Therapeutics Inc Expected to Post a Loss of 30 Cents a Share - Earnings Preview

Reuters
·
Aug 03

Biocytogen, Whitehawk Therapeutics Team up on Bispecific Antibody-drug Conjugate Development

Reuters
·
Jul 07

Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development

THOMSON REUTERS
·
Jul 07

Whitehawk Therapeutics Inc: Additional Financial Terms were not Disclosed

THOMSON REUTERS
·
Jul 07

Whitehawk Therapeutics - Biocytogen to Receive Upfront Payment, Milestone Payments, and Low Single-digit Royalties

THOMSON REUTERS
·
Jul 07

Whitehawk Therapeutics Initiated at Buy by B. Riley Securities

Dow Jones
·
Jun 25

Whitehawk Therapeutics Inc : B. Riley Initiates Coverage with Buy Rating; Target Price $10

THOMSON REUTERS
·
Jun 25

Whitehawk Therapeutics shareholders ratified BDO USA as independent auditor

Reuters
·
Jun 13

Whitehawk Therapeutics presents real-world analysis on SEZ6

TIPRANKS
·
Jun 01

Whitehawk says Tempus-backed analysis supports SEZ6 as SCLC target for HWK-206 ADC ahead of mid-2026 IND

Reuters
·
May 31